Imperial College London

DrAbbasDehghan

Faculty of MedicineSchool of Public Health

Reader in Cardiometabolic Disease Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 3347a.dehghan CV

 
 
//

Location

 

157Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Gill:2018:10.1161/STROKEAHA.118.022701,
author = {Gill, D and Monori, G and Tzoulaki, I and Dehghan, A},
doi = {10.1161/STROKEAHA.118.022701},
journal = {Stroke},
pages = {2815--2821},
title = {Iron status and risk of stroke},
url = {http://dx.doi.org/10.1161/STROKEAHA.118.022701},
volume = {49},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Background and Purpose- Both iron deficiency and excess have been associated with stroke risk in observational studies. However, such associations may be attributable to confounding from environmental factors. This study uses the Mendelian randomization technique to overcome these limitations by investigating the association between genetic variants related to iron status and stroke risk. Methods- A study of 48 972 subjects performed by the Genetics of Iron Status consortium identified genetic variants with concordant relations to 4 biomarkers of iron status (serum iron, transferrin saturation, ferritin, and transferrin) that supported their use as instruments for overall iron status. Genetic estimates from the MEGASTROKE consortium were used to investigate the association between the same genetic variants and stroke risk. The 2-sample ratio method Mendelian randomization approach was used for the main analysis, with the MR-Egger and weighted median techniques used in sensitivity analyses. Results- The main results, reported as odds ratio (OR) of stroke per SD unit increase in genetically determined iron status biomarker, showed a detrimental effect of increased iron status on stroke risk (serum iron OR, 1.07; 95% CI, 1.01-1.14; [log-transformed] ferritin OR, 1.18; 95% CI, 1.02-1.36; and transferrin saturation OR, 1.06; 95% CI, 1.01-1.11). A higher transferrin, indicative of lower iron status, was also associated with decreased stroke risk (OR, 0.92; 95% CI, 0.86-0.99). Examining ischemic stroke subtypes, we found the detrimental effect of iron status to be driven by cardioembolic stroke. These results were supported in statistical sensitivity analyses more robust to the inclusion of pleiotropic variants. Conclusions- This study provides Mendelian randomization evidence that higher iron status is associated with increased stroke risk and, in particular, cardioembolic stroke. Further work is required to investigate the underlying mechanism and whether this can
AU - Gill,D
AU - Monori,G
AU - Tzoulaki,I
AU - Dehghan,A
DO - 10.1161/STROKEAHA.118.022701
EP - 2821
PY - 2018///
SN - 0039-2499
SP - 2815
TI - Iron status and risk of stroke
T2 - Stroke
UR - http://dx.doi.org/10.1161/STROKEAHA.118.022701
UR - https://www.ncbi.nlm.nih.gov/pubmed/30571402
UR - http://hdl.handle.net/10044/1/65956
VL - 49
ER -